133 related articles for article (PubMed ID: 12490547)
21. Arrhythmogenic action of endothelin peptides in isolated perfused whole hearts from guinea pigs and rats.
Ercan ZS; Ilhan M; Kilinç M; Türker RK
Pharmacology; 1996 Oct; 53(4):234-40. PubMed ID: 8958562
[TBL] [Abstract][Full Text] [Related]
22. Contribution of endogenous endothelin to large epicardial coronary artery tone in dogs and humans.
Thorin E; Parent R; Ming Z; Lavallée M
Am J Physiol; 1999 Aug; 277(2):H524-32. PubMed ID: 10444477
[TBL] [Abstract][Full Text] [Related]
23. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.
Ivy DD; Kinsella JP; Abman SH
J Clin Invest; 1994 May; 93(5):2141-8. PubMed ID: 8182146
[TBL] [Abstract][Full Text] [Related]
24. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction.
Amiri F; Virdis A; Neves MF; Iglarz M; Seidah NG; Touyz RM; Reudelhuber TL; Schiffrin EL
Circulation; 2004 Oct; 110(15):2233-40. PubMed ID: 15466627
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.
Chatziantoniou C; Boffa JJ; Ardaillou R; Dussaule JC
J Clin Invest; 1998 Jun; 101(12):2780-9. PubMed ID: 9637712
[TBL] [Abstract][Full Text] [Related]
26. Action of protein kinase C in endothelin-induced contractions in rat aortic rings.
Oriji GK; Keiser HR
Am J Physiol; 1996 Jul; 271(1 Pt 1):C398-404. PubMed ID: 8760071
[TBL] [Abstract][Full Text] [Related]
27. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
Li L; Watts SW; Banes AK; Galligan JJ; Fink GD; Chen AF
Hypertension; 2003 Sep; 42(3):316-21. PubMed ID: 12885792
[TBL] [Abstract][Full Text] [Related]
28. Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1.
Ruschitzka F; Shaw S; Gygi D; Noll G; Barton M; Lüscher TF
J Am Soc Nephrol; 1999 May; 10(5):953-62. PubMed ID: 10232680
[TBL] [Abstract][Full Text] [Related]
29. Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinyl leukotrienes and endothelin-1.
Chłopicki S; Bartuś JB; Gryglewski RJ
Pol J Pharmacol; 2002; 54(5):433-41. PubMed ID: 12593530
[TBL] [Abstract][Full Text] [Related]
30. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice.
Barton M; Haudenschild CC; d'Uscio LV; Shaw S; Münter K; Lüscher TF
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14367-72. PubMed ID: 9826706
[TBL] [Abstract][Full Text] [Related]
31. Endothelium is required in the vascular spasm induced by tetraethylammonium and endothelin-1 in guinea-pig aorta.
Dorigo P; Maragno I; Santostasi G; Fraccarollo D
Br J Pharmacol; 1999 May; 127(2):505-13. PubMed ID: 10385252
[TBL] [Abstract][Full Text] [Related]
32. Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion.
Gourine AV; Gonon AT; Pernow J
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1105-12. PubMed ID: 11179053
[TBL] [Abstract][Full Text] [Related]
33. Endothelin-1 potentiation of coronary artery contraction after ischemia-reperfusion.
García-Villalón AL; Amezquita YM; Monge L; Fernández N; Salcedo A; Diéguez G
Vascul Pharmacol; 2008; 48(2-3):109-14. PubMed ID: 18262852
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin.
Ruschitzka FT; Wenger RH; Stallmach T; Quaschning T; de Wit C; Wagner K; Labugger R; Kelm M; Noll G; Rülicke T; Shaw S; Lindberg RL; Rodenwaldt B; Lutz H; Bauer C; Lüscher TF; Gassmann M
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11609-13. PubMed ID: 11027359
[TBL] [Abstract][Full Text] [Related]
35. Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro.
Maguire JJ; Kuc RE; Davenport AP
Br J Pharmacol; 2001 Nov; 134(6):1360-6. PubMed ID: 11704658
[TBL] [Abstract][Full Text] [Related]
36. Marked heterogeneity of endothelin-mediated contractility and contraction dynamics in mouse renal and femoral arteries.
Widmer CC; Mundy AL; Kretz M; Barton M
Exp Biol Med (Maywood); 2006 Jun; 231(6):777-81. PubMed ID: 16740998
[TBL] [Abstract][Full Text] [Related]
37. Interaction of endothelin-1 and nitric oxide in endothelial barrier failure in the cat hindlimb.
Porter LP; McNamee JE; Wolf MB
Microcirculation; 2000 Oct; 7(5):347-56. PubMed ID: 11079252
[TBL] [Abstract][Full Text] [Related]
38. Role of endogenous endothelin in endothelial dysfunction in murine model of systemic sclerosis: tight skin mice 1.
Richard V; Solans V; Favre J; Henry JP; Lallemand F; Thuillez C; Marie I
Fundam Clin Pharmacol; 2008 Dec; 22(6):649-55. PubMed ID: 19049669
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation.
Barton M; Shaw S; d'Uscio LV; Moreau P; Lüscher TF
Biochem Biophys Res Commun; 1997 Sep; 238(3):861-5. PubMed ID: 9325182
[TBL] [Abstract][Full Text] [Related]
40. Role of erythropoietin and nitric oxide in modulating the tone of human renal interlobular and subcutaneous arteries from uraemic subjects.
Wu XC; Richards NT; Johns EJ
Clin Sci (Lond); 1999 Dec; 97(6):639-47. PubMed ID: 10585891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
